Sponsored by

Anna's Daybreak News

_{Just facts, you think for yourself}

Tuesday, 5:20 AM

April 21, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Apple’s Change of Reign

Apple named John Ternus CEO effective September 1, 2026, succeeding Tim Cook, who will become executive chairman. Ternus, at Apple since 2001, leads hardware engineering and joins the board.

Cook, CEO since 2011, grew Apple’s market value from $350 billion to $4 trillion and revenue from $108 billion to $416 billion. He launched Apple Watch, AirPods, Vision Pro, expanded services to over $100 billion revenue, and grew devices to 2.5 billion active units.

Cook managed supply chain issues, tariffs, and led the shift to Apple silicon. Under Cook, Apple cut its carbon footprint by 60% and emphasized privacy and inclusion. Ternus’s projects include MacBook Neo and iPhone 17 with eco-friendly designs.

Sources: WallStreetJournal, Apple, CNBC, Nbcnews

Kash Patel Sues The Atlantic

FBI Director Kash Patel sued The Atlantic for $250 million over a defamation article alleging his alcohol use impaired his job performance and caused FBI delays.

The Atlantic cited over two dozen anonymous sources fearing security risks. Patel denies the claims, citing a pre-publication refutation letter ignored by the outlet, accusing it of “actual malice.” The Atlantic defends the article; it is majority-owned by Emerson Collective.

The lawsuit is part of a broader wave of legal actions by Trump administration figures against media outlets, including lawsuits by Trump against CNN, the New York Times, and The Wall Street Journal, with some dismissed and others settled for millions.

Sources: WallStreetJournal, Reuters, AP News

Cabinet Shakeup: Labor Exit

Labor Secretary Lori Chavez-DeRemer resigned amid investigations into misuse of Labor Department funds, travel fraud, workplace drinking, and an inappropriate relationship with a staffer.

Several aides were placed on leave as the inspector general probe continues. Her husband faced accusations of inappropriate touching, but authorities found no criminal evidence.

Chavez-DeRemer, a former Republican congresswoman, supported labor unions and backed a 2023 bill expanding collective-bargaining rights. Her tenure included an executive order granting private equity firms access to the $14 trillion retirement market.

Deputy Labor Secretary Keith Sonderling will serve as acting secretary. Her resignation is the third cabinet exit under President Trump in two months, raising congressional concerns.

Sources: AP News, Bloomberg, WallStreetJournal

Japan Arms Shift

Japan has ended its post-WWII ban on lethal arms exports, allowing defense companies to sell weapons directly to 17 countries.

The policy shift, approved by PM Sanae Takaichi responds to security threats from China, North Korea, and Russia, and doubts about U.S. commitment amid its Iran war.

Japan recently secured a $6.5 billion warship deal with Australia and plans further security ties with Vietnam and Australia. Exports exclude nations in active conflict unless national security is threatened.

Japanese firms like Mitsubishi Heavy Industries and Kawasaki Heavy Industries are set to expand globally. China condemned the move, increasing regional tensions after Japan’s Taiwan Strait warship transit.

Sources: Co, NYTimes, FinancialTimes

Reversing Osteoporosis

Researchers identified the receptor GPR133 as a regulator of bone strength by promoting osteoblasts and inhibiting osteoclasts.

Activating GPR133 with AP503 increased bone density and strength in healthy and osteoporotic mice, including models of postmenopausal bone loss. Genetic links associate GPR133 with bone mineral density and height.

AP503 also enhanced skeletal muscle strength, potentially addressing combined bone and muscle loss in aging populations. Current osteoporosis treatments have drawbacks; targeting GPR133 could offer safer, longer-lasting effects.

The research is at the animal study stage, with further investigation planned before human trials. This discovery may transform osteoporosis and low bone mass disorder treatments.

Sources: SciTechDaily

Fatty Liver Breakthrough

UCLA researchers identified senescent macrophages—immune cells marked by p21 and TREM2—that accumulate in aging livers and drive inflammation.

In mice, these cells rose from 5% to 60-80% with age and increased under high LDL cholesterol. Administering ABT-263, which kills senescent cells, reduced liver size and fat, and lowered overall body weight despite continued unhealthy diets.

In humans, these cells were more abundant in diseased livers, common in fatty liver disease affecting 30-40% of Los Angeles residents. ABT-263 is too toxic for human use, prompting the search for safer alternatives.

The study suggests targeting senescent macrophages could treat aging-related diseases like Alzheimer's and atherosclerosis.

Sources: SciTechDaily

“A man ought to base his actions on plain, cold horse-sense, not pure, mule-headed stubbornness.”

Baked with love,

Anna Eisenberg ❤️